Green Lifescience Co., Ltd. (KOSDAQ:114450)
2,335.00
+75.00 (3.32%)
At close: Aug 18, 2026
Green Lifescience Revenue
Green Lifescience had revenue of 15.55B KRW in the quarter ending March 31, 2026, with 219.16% growth. This brings the company's revenue in the last twelve months to 51.02B, up 119.98% year-over-year. In the year 2025, Green Lifescience had annual revenue of 40.34B with 62.26% growth.
Revenue (ttm)
51.02B
Revenue Growth
+119.98%
P/S Ratio
0.89
Revenue / Employee
728.81M
Employees
70
Market Cap
45.59B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.34B | 15.48B | 62.26% |
| Dec 31, 2024 | 24.86B | 2.49B | 11.14% |
| Dec 31, 2023 | 22.37B | -14.14B | -38.72% |
| Dec 31, 2022 | 36.50B | 11.17B | 44.07% |
| Dec 31, 2021 | 25.34B | 776.97M | 3.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| TOP Engineering | 858.80B |
| Korea Asset Investment Securities | 245.07B |
| Samchuly Bicycle | 170.73B |
| DK&D Co.,Ltd | 148.77B |
| Genoray | 108.27B |
| Abko Co., Ltd. | 76.82B |
| The Asia Business Daily | 73.03B |
| Actoz Soft | 66.56B |